Equitus Consulting Inc.
Flower

ReVue Drug Evaluation Group

revuelogo

Founded in 1999, ReVue Drug Evaluation Group carries out evaluation of new drug entities on behalf of major third-party payors in the private sector. These evaluations are based on material provided by the pharmaceutical manufacturers as well as external data bases such as Cochrane and MedLine and look at both the clinical and economic aspects of the drug under review.

Based on the evaluations prepared by ReVue, payor clients determine how the drug will be treated under the various formularies that they manage.

ReVue also provides counsel to pharmaceutical companies on strategic positioning as well as carrying out custom work such as therapeutic class reviews for payors and pharmaceutical companies.

The principals of ReVue Drug Evaluation Group are:

Equitus Consulting Inc.

Dr. Mitchell Levine MD, M.Sc., FRCPC
Dr. Levine is the Director of the Centre for Evaluation of Medicines, St. Joseph’s Hospital, Hamilton and is Associate Professor in the Department of Epidemiology and Biostatistics and the Department of Medicine at McMaster University in Hamilton.

Dr. Jacques Le Lorier
Dr. Le Lorier is Chief, Pharmacoepidemiology and pharmacoeconomy research unit Research Centre, Centre hospitalier de l’ de Montreal, Campus Hotel Dieu. He is also a Professor in the Departments of Medicine and Pharmacology, Faculty of Medicine, University of Montreal.

ReVue uses the services of external reviewers, matching the expertise of the reviewer with the therapeutics that are under review. Reviewers include:

Laura Park, B.Sc.Pharm., Pharm.D., M.Sc. Candidate. Consultant, Integra Health
Laura Park graduated from the University of Toronto with her Bachelor of Science in Pharmacy in 1995, and then completed a pharmacy residency at the Ottawa General Hospital. After completing her Doctor of Pharmacy in 1999, she engaged in a primary care practice with HIV-positive patients. Laura is actively involved in research addressing medication adherence and continues to provide consulting services to community, pharmaceutical industry, and insurance clients. Laura is completing her Masters in Health Research Methodology at McMaster University and was the recipient of the Ontario HIV Treatment Network Research Scholar award for 2000-01.

Andrew R.J. Wyllie, B.Sc.Pharm., Pharm.D. Consultant, Integra Health
Andrew Wyllie earned a bachelor of science in Pharmacy from the University of Toronto in 1995 and then completed a pharmacy residency at the London Health Sciences Centre in London, Ontario. After completing his Doctor of Pharmacy in 1999, he practiced as a consultant for community pharmacists, the pharmaceutical industry and insurance parties. Andrew is now a drug information pharmacist in the Toronto area and continues to provide consulting services to various clients.

Wendy Gordon
Wendy Gordon received a Baccalaureate of Arts (Chemistry) from Queens University, a Baccalaureate of Science and a Doctorate of Pharmacy from the University of British Columbia. She is a member of the Canadian Cardiovascular Society, the College of Pharmacists of British Columbia and the Canadian Society of Hospital Pharmacists. For the past 13 years Dr. Gordon has been a clinical specialist in cardiology at Royal Columbian Hospital in New Westminster B.C. She is a Clinical Instructor in both the UBC Doctor of Pharmacy program as well as the University of Toronto Distance Doctor of Pharmacy Program. Dr. Gordon has a considerable body of research and publication work to her credit including authorship of “The pharmacists guide to cardiology: Heart failure, hypertension and acute coronary syndrome”.

Nancy Parsons
Nancy Parson has enjoyed over 20 years of pharmaceutical and biopharmaceutical experience. She secured her M.Sc. in the field of Developmental Biology and following her degree conducted clinical research in endocrinology before joining the pharmaceutical industry with Bristol Labs. Nancy has extensive experience in the biotechnology industry with both Genentech Canada and Amgen Canada where her responsibilities included clinical trial work, product launches, pharmacoeconomic analyses, reimbursement and Sales and Product Management. Nancy managed all business functions, as General Manager, for the Canadian operations of the Liposome Company, Elan Pharmaceuticals, Enzon Pharmaceuticals and Sopherion Therapeutics Canada, Inc.

Andrew Wyllie
Andrew Wyllie is a drug information pharmacist at Mount Sinai Hospital in Toronto. He holds a bachelor and a doctorate degree in Pharmacy from University of Toronto, and completed a hospital pharmacy residency at London Health Sciences Centre. He precepts pharmacy residents and PharmD students in drug information and critical appraisal. He enjoys debates with students and colleagues about how to interpret and apply studies to clinical practice . Andrew is the secretary for the Pharmacotherapy and Safe Medication Practices committee which oversees the safe and effective use of medicines at Mount Sinai.